GET STARTED WITH COMPLIATRIC!
Schedule a demo and organize your compliance program on one secure cloud-based platform today.
The Medication Access and Training Expansion (MATE) Act (Section 1263 of the Consolidated Appropriations Act of 2023) requires new or renewing DEA registrants, as of Tuesday, June 27, 2023, to have completed a total of at least eight hours of training on opioid or other substance use disorders. The official letter is available here.
This training is to be renewed every three years. The MATE Act was enacted as a part of the Consolidated Appropriations Act of 2023 to ensure responsible prescription of addictive drugs and to combat the opioid crisis in the United States.
Training requirements can be satisfied through diverse mediums such as formal courses, seminars, professional society events, online modules, and quizzes. These can be administered by accredited bodies like the American Society of Addiction Medicine (ASAM), the American Medical Association (AMA), the American Dental Association (ADA), the American Psychiatric Association (APA), and the American Nurses Credentialing Center (ANCC), among others.
Notably, past training in the treatment and management of patients with substance use disorders conducted by any of these accredited organizations can be counted towards fulfilling the requirement.
Exemptions apply to practitioners with Board Certification in addiction medicine or addiction psychiatry from recognized bodies. Additionally, recent graduates (within the past five years) from medical, dental, physician assistant, or advanced practice nursing schools in the U.S are also exempted if their curriculum included an equivalent eight-hour course.
To ensure compliance, consider the following strategies: